Filing Details

Accession Number:
0000950170-24-026472
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-05 18:16:08
Reporting Period:
2024-03-01
Accepted Time:
2024-03-05 18:16:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1756262 Transmedics Group Inc. TMDX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1190128 R James Tobin C/O Transmedics Group, Inc.
200 Minuteman Road
Andover MA 01810
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-03-01 200 $81.41 233,391 No 4 S Indirect By the James R. Tobin 2012 Trust
Common Stock Disposition 2024-03-01 4,234 $82.84 229,157 No 4 S Indirect By the James R. Tobin 2012 Trust
Common Stock Disposition 2024-03-01 5,746 $83.63 223,411 No 4 S Indirect By the James R. Tobin 2012 Trust
Common Stock Disposition 2024-03-01 2,900 $84.74 220,511 No 4 S Indirect By the James R. Tobin 2012 Trust
Common Stock Disposition 2024-03-01 300 $85.48 220,211 No 4 S Indirect By the James R. Tobin 2012 Trust
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By the James R. Tobin 2012 Trust
No 4 S Indirect By the James R. Tobin 2012 Trust
No 4 S Indirect By the James R. Tobin 2012 Trust
No 4 S Indirect By the James R. Tobin 2012 Trust
No 4 S Indirect By the James R. Tobin 2012 Trust
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,193 Direct
Footnotes
  1. The reported transactions were effected pursuant to a Rule 10b5-1 trading plan entered into on November 21, 2023.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $82.25 to $83.22, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  3. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $83.26 to $84.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  4. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $84.28 to $85.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
  5. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $85.39 to $85.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.